Background
Pain assessment in cognitively impaired older people is complex (Marzinski 1991 , Ferrell 1995 , and is often a reason for excluding them from pain studies (Wynne et al. 2000) . A reflection of this complexity might be that older people with cognitive impairment use fewer analgesics than those who are cognitively intact (Marzinski 1991) . One possible explanation is that the neuropathology in, for example, Alzheimer's disease (AD) might alter the actual pain experience (Scherder et al. 2003a) . Many areas of the brain that are affected in AD (e.g. the prefrontal cortex, anterior cingulate cortex, and hippocampus; Braak & Braak 1991) , are also involved in processing the affective components of pain (Treede et al. 1999) . Some of these areas, e.g. the hippocampus, are already affected at an early stage of AD (Braak & Braak 1991) .
A lower use of analgesics in patients with dementia might also reflect an undertreatment of pain. First, a patient with dementia may underreport pain because he has forgotten that he was in pain. However, a recent study that reduced the impact of memory by assessing pain in patients with AD repeatedly, that is, daily at varying times and during different periods, showed that, irrespective of the assessment frequencies and periods, patients with AD were still reported to experience less intensity and effect of pain than older people without dementia (Scherder et al. 2001) . Alternatively, one might wonder whether carers are capable of identifying pain in older persons. In a study by Middleton et al. (1997) no significant differences in pain ratings were observed between residents, Residents' Assistants (RAs) and Registered Nurses (RNs). It is worth noting that only the pain ratings of the cognitively intact older people were compared with the ratings of both the RAs and the RNs. Interestingly, the ratings by the RAs were higher than those of the RNs. A suggested explanation was that, compared with the RNs, the RAs are more personally involved in the caring process. Similar findings were observed in a more recent study (Blomqvist & Hallberg 2001) .
In contrast, the capability of carers to assess pain accurately in persons with dementia has been questioned (Cook et al. 1999) . In a group of chronic care nursing home residents, there was a discrepancy between the nursing staff's evaluation of the residents' pain and the residents' evaluation of their own pain (Weiner et al. 1999 ). Unfortunately, although the level of cognitive functioning varied from normal to impaired, data analyses were performed over the whole group. One could speculate that the lower the level of cognitive functions, the higher the discrepancy in assessment between the two groups would be. People with mild to moderate cognitive impairment participated in the study of Engle et al. (2001) . Licensed practical nurses and, to lesser extent, nursing assistants (NAs), underestimated the pain of these people. In another study, NAs overestimated the pain experienced by some of those with cognitive impairment (Horgas & Dunn 2001) .
In summary, the results of several studies indicate a discrepancy between perceptions of pain by the residents with cognitive impairment and by their caregivers (Engle et al. 2001 , Horgas & Dunn 2001 . This is not illogical because there is now increasing evidence that at least some patients with AD might experience a decrease in pain (Scherder et al. 2001) , whereas a subgroup of patients with vascular dementia might show enhanced pain perception (Scherder et al. 2003a,b) . Knowledge about the relation between the type of dementia, its underlying neuropathology, and pain could be of great value for the nurses who have to evaluate the residents' pain. Unfortunately, at least in the Netherlands, the education of NAs does not yet incorporate the latest insights into the complex relationship between subtypes of dementia and pain.
The study Aim
The aim of the study was to compare the assessment by NAs of the pain experienced by patients with AD with the patients' own evaluation and to contribute to the knowledge of NAs about the influence of subtypes of dementia on experience of pain. 
Participants
Participants were recruited from two Dutch nursing homes. The sample consisted of two groups: 20 patients with probable AD at stage 5 of the Global Deterioration Scale (Reisberg et al. 1982) , and 17 older people without dementia. All patients with AD met the criteria of the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer's Disease and Related Disorders Association (ADRDA) for the clinical diagnosis of 'probable' AD (McKhann et al. 1984) . Participants were excluded from participation if they had vision problems, a history of psychiatric disorder (particularly depression not related to dementia), alcoholism, cerebral trauma, cerebrovascular disease, hydrocephalus, neoplasm, epilepsy, disturbances of consciousness, or focal brain disorders.
This study, which deals in part with the assessment of pain during and after walking, necessitated that the participants had to suffer from chronic painful conditions, preferably in the lower extremities and the spinal column. Also the number of painful conditions within each participant was recorded. Within the AD group, 15 patients had one painful condition (e.g. arthrosis), five patients suffered from two painful conditions (e.g. osteoporosis in the spinal column plus arthrosis of the hip). In the non-demented group, 12 older people had one painful condition, whereas five participants suffered from two painful conditions. The number of painful conditions in the AD-group (M ¼ 1AE25) and in the non- NS) . No other chronic painful conditions were present in the participants of both groups. All participants were able to walk, in most cases with a walking aid.
Pain assessment instruments
In order to assess pain, three visual analogue scales and one observation scale were administered. The visual analogue scales, initially developed for very young children who do not yet have fully developed memory and language capacities (Bieri et al. 1990 , McGrath et al. 1996 , were reliably administered in previous studies with patients with AD (Ferrell et al. 1990 , Scherder & Bouma 2000 , Scherder et al. 2001 . The following scales were used.
Coloured Analogue Scale for the Assessment of Pain Intensity
The Coloured Analogue Scale (CAS) for the Assessment of Pain Intensity (McGrath et al. 1996) was designed to assess the intensity of pain, in a non-verbal way ( Figure 1 ). This uses different colours and areas, which facilitate the participant's selection of a scale position that best reflects his pain intensity. Selecting the appropriate scale position is done by sliding a horizontal marker from the bottom (no pain) to the top (maximum pain). The participant's score is the numerical value on the back of the scale that matches the selected scale position, with scores ranging from 0 to 100.
Coloured Analogue Scale for the Assessment of Pain Affect
The CAS for the Assessment of Pain Affect (McGrath et al. 1996) was used to assess the extent of suffering from the participant's own painful condition(s). The label 'no pain' at the bottom was replaced by the label 'no suffering', and the label 'maximum pain' at the top by the label 'a great deal of suffering'. Similar to the original CAS, each scale position referred to a number (a numerical value) on the back of the scale.
Faces Pain Scale
The Faces Pain Scale (FPS) (Bieri et al. 1990 ) measures the severity and affective components of pain and can be reliably and validly administered to children as young as 3 years of age ( Figure 2 ). The FPS consists of line drawings of seven faces, that is, one neutral face and six faces that express increasing feelings of pain. Participants could rank their feelings from 'no pain' (score 0, the neutral face), to 'most severe pain' (score 6, the face expressing most feelings of pain), with the score ranging from 0 to 6.
Checklist of Non-verbal Pain Indicators
The Checklist of Non-verbal Pain Indicators (CNPI) (Feldt 2000) is an observational scale designed to measure verbal and non-verbal pain behaviours. The scale is scored while the participant is sitting quietly and during a walk. The checklist includes five non-verbal behaviours: (1) non-verbal vocalizations -moans; (2) grimacing -furrowed brow; (3) bracingclutching; (4) restlessness -constant or intermittent shifting of position; (5) rubbing -massaging the affected area. In addition, verbal pain indicators were recorded, for example, 'that hurts'. Each pain indicator is scored with one point if present, and no points if not present (maximum score ¼ 6). 
Comprehension of the scales
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Pain in Alzheimer's disease scale). For the FPS, the participants had to indicate which face showed most pain and which face showed least pain.
Training of interviewers
The first author (EJAS) who has studied the influence of dementia on pain for a number of years using the same pain assessment instruments (visual analogue scales, observation scale; Scherder & Bouma 2000 , Scherder et al. 2003b , instructed the second author (FJvM) intensively about the assessment procedures before the start of the study.
Data collection
Experience of pain by participants The three visual analogue scales were administered before and after walking a short distance. During standing up, walking and sitting down, the investigator filled in the CNPI. All participants were asked to indicate the extent of their present pain.
Participants' pain assessed by nursing auxiliaries
The NA who had the closest relationship with the resident was asked to participate. The qualified NAs had trained for 3 years, during which time they had acquired specific nursing skills. Due to a shortage of staff, each resident has only one personal NA. All NAs fully understood the meaning of the scales. By means of the three visual analogue scales, the NAs were asked to indicate the present pain status of the participants before and after walking a short distance. The CNPI was not administered to the NAs.
Sequence of administration
To optimize objectivity, the sequence in which the participants and the NAs were approached with the scales was random: first the participant and subsequently the NA, and then in the reverse order.
Ethical considerations
The study was approved by a local ethics committee for patient-related scientific research. After the first global screening, the participants and their families/representatives were extensively informed about the purpose of the study and gave their written informed consent.
Data analysis
The main goal of the study was to examine the level of agreement between the pain perception of patients with AD, older patients without dementia and that of the NAs.
Although we have hypothesized that the NAs will overestimate pain in patients with AD, it is also possible that the NAs estimate the pain in some patients at a lower level. Therefore, first subtracting the scores of the NAs scores from those obtained from the participants (with and without dementia) and subsequently transforming negative scores into positive scores, we calculated absolute differences. Pain was assessed in two conditions using the same assessment method: at rest and after walking. Using the SPSS-PC program (Norusis 1992) , analysis of variances (ANOVA ANOVAs) and Mann-Whitney Utests were used to assess NAs' estimation of participants' pain and the pain experience of participants themselves under each of these two separate conditions. In addition, chi-square tests and paired t-tests were used. (Folstein et al. 1975) . Participants with a score between 15 and 25 were classified as having mild cognitive deterioration. A score of over 24 indicated normal cognitive functioning. The mean MMSE-score of the patients with AD and the older people without dementia differed significantly (Mann-Whitney U-test: Z ¼ 5AE22, P < 0AE000) ( Table 1) .
Pain assessment
For each separate scale, the data will be presented as follows: (a) comprehension of the scale; (b) absolute differences in pain scores between participants and NAs, and (c) actual pain experience of the participants. Only those participants who understood the meaning of the scale were included in the analyses.
CAS for pain intensity
Comprehension of the scale. All older people without dementia understood the concept of the scale. Only one patient with AD (5%) failed to comprehend the meaning of the scale.
Absolute differences in pain scores between participants and NAs. Irrespective of rest or walking, ANOVA ANOVA indicated that the absolute difference between the perception of pain by NAs and patients with AD was significantly larger than the absolute difference in pain scores between the NAs and those in the non-demented group. For means, standard deviations, ANOVA ANOVA, and effect-size, see Table 2 .
Within the AD group, paired t-tests further showed that the pain scores by the NAs were significantly higher than those of the patients with AD, both at rest [t (18) Actual pain experience of patients with AD vs. participants without dementia. Data analyses show that patients with AD experienced considerably less pain than the older people without dementia, both at rest and after walking. For means, standard deviations, and Mann-Whitney U-tests, see Table 3 .
CAS for Pain Affect Comprehension of the scale. All persons without dementia and all patients with AD fully understood the concept of the scale.
Absolute differences in pain scores between participants and NAs. Similar to CAS for Pain Intensity, ANOVA ANOVA showed that the absolute difference between the perception of pain by patients with AD and NAs was significantly larger than the absolute difference in pain scores between the NAs and those people without dementia, irrespective of whether at rest or walking (see Table 2 ).
Also in line with the scores on CAS for Pain Intensity, paired samples t-tests indicated that within the AD group the NAs overestimated the patients' pain significantly both at rest [t(19) Actual pain experience of patients with AD compared with older people without dementia. Analyses of the data obtained at rest and after walking indicate that, compared with the group without dementia, the reduction in pain experience in patients with AD was significant and showed a trend, respectively. For means, standard deviations, and Mann-Whitney U-tests, see Table 3 .
Faces Pain Scale
Comprehension of the scale. Although one person of those without dementia misunderstood the concept of the scale (5AE9%), only 13 of 20 AD patients (65%) actually understood the meaning of the FPS. Intensity  23AE97  27AE03  41AE71  22AE53  6AE72  1,34  0AE007  0AE89  CAS for Pain Affect  18AE53  16AE80  40AE50  32AE45  6AE33  1,35  0AE009  0AE80  Faces Pain Scale  1AE75  1AE00  2AE08  1AE71  0AE42  1,27  0AE53  0AE21  Pain after walking  CAS for Pain Intensity  27AE03  20AE36  41AE94  28AE00  3AE08  1,32  0AE04  0AE55  CAS for Pain Affect  21AE72  18AE09  44AE32  34AE52  5AE55  1,33  0AE01  0AE86  Faces Pain Scale  1AE73  1AE23  2AE08  1AE78  0AE37  1,25  0AE55  0AE17 CAS, Coloured Analogue Scale; AD, Alzheimer's disease.
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Pain in Alzheimer's disease Absolute differences in pain scores between participants and NAs. Analyses of variance showed that the absolute difference in pain evaluation between the NAs and the patients was neither significantly higher nor significantly lower than the difference in pain evaluation between that of the NAs and those people without dementia, both at rest and after walking. For means, standard deviations, ANOVA ANOVA, and effect-sizes, see Table 2 .
Actual pain experience of patients with AD vs. participants without dementia. With respect to the pain measurements at rest and after walking, the lower scores on this scale by the patients with AD in comparison with the older people without dementia showed a trend. For means, standard deviations, and Mann-Whitney U-tests, see Table 3 .
Checklist for Non-verbal Pain Indicators Actual pain experience of patients with AD vs. participants without dementia. Data analyses indicated that the group with AD and the group without dementia did not show a significant difference in scores on the CNPI. For means, standard deviations and Mann-Whitney U-tests, see Table 3 .
Discussion
Comprehension of the various scales CAS. The results show that none of the participants without dementia and only one patient with AD misinterpreted the CAS for Pain Intensity. None of the participants failed to understand the proper meaning of the CAS for Pain Affect.
FPS.
Seven of 20 patients with AD misinterpreted the purpose of the scale. In the group without dementia, the proper meaning of the scale was unclear for only one person. These results are quite similar to those observed in earlier studies (Scherder & Bouma 2000 , Scherder et al. 2001 ).
Absolute differences in pain scores between participants and NAs CAS for Pain Intensity and Pain Affect. Both at rest and after walking, the absolute difference in pain scores between the NAs and the participants in the non-demented group was much smaller than the difference in pain evaluation between the NAs and the patients with AD.
FPS. Although the difference in pain perception between the NAs and the participants was somewhat smaller in the group without dementia than in the group with AD, this difference was not significant. The scores on the FPS have a smaller range (0-6) than the CAS scales (0-100) and may therefore be less capable of measuring more subtle differences in pain evaluation.
Importantly, particularly the difference in pain scores on both the CAS scales and, to a lesser degree, the difference in scores on the FPS between the NAs and the patients with AD confirm our hypothesis that NAs overestimated the pain experience in the group with AD (Table 2 ). It is notable that the difference between estimations by NAs and patients with AD with respect to pain at rest, measured using both the CAS for Pain Intensity and Pain Affect, showed a large effect size. Considering pain after walking, the difference in estimations Table 3 Means and standard deviations of the actual pain experience as perceived by the participants (patients with AD and older people without dementia) and by the nursing assistants (NAs). Differences in actual pain experience between patients with AD and participants without dementia were analysed using Mann-Whitney U-tests between the NAs and the patients with AD in scores on the CAS for Pain Intensity again had a large effect size, whereas a medium effect size was noted when the CAS for Pain Affect was used. In a previous study (Horgas & Dunn 2001) , the overestimation of pain by the NAs was explained by their need to show that patients are adequately cared for in a nursing home setting. However, an overestimation of pain might lead to an excess of analgesic prescription, risking possibly harmful side-effects and causing unnecessary costs for the healthcare system. Better education and thus knowledge about the relation between subtypes of dementia and its underlying neuropathology would contribute greatly to the reliability of pain assessment (Scherder et al. 2003a ) and consequently to pain treatment (Horgas & Dunn 2001) ; for example, atrophy of areas such as the hippocampus may cause a decrease in affective pain processing, whereas white matter lesions may provoke an increase in pain (Scherder et al. 2003a ).
Actual pain experience of patients with AD vs. participants without dementia CAS for Pain Intensity, CAS for Pain Affect, and the FPS. The results show that, irrespective of whether at rest or walking, the patients with AD in the present study indicated that they experienced less pain intensity and suffered less from pain than older people without dementia.
Although we had similar findings in earlier studies (Scherder & Bouma 2000 , Scherder et al. 2001 , great caution should be exercised in generalizing these findings to all patients with AD.
CNPI. The finding that there was no difference in scores between both groups might be caused by the fact that the items of the CNPI reflect rather high levels of pain intensity, such as groans, grimacing, or cursing during movement. The highest level of pain intensity -in the present study indicated by the group of older people without dementia -was only moderate (Table 2) .
Study limitations
First, despite the fact that pain assessment occurred at rest and after walking, it took place at only one specific moment. Secondly, each resident has only one NA who knows the mental and physical condition of the resident the best. Consequently, interrater reliability could not be calculated. Furthermore, as the NAs estimated the pain of the patients with AD to be as high as the pain of the participants without dementia, it would be interesting in future research to consider the amount of pain medication required in relationship to the NAs' opinions. Finally, it is unclear whether the apparent diminished pain experience in patients with AD can be generalized to other types of dementia. In future research about pain assessment and dementia, it is therefore important to differentiate between the particular types of dementia.
Conclusion
The observed overestimation by NAs of patients' pain might specifically be related to AD, because AD is characterized by a decrease in the pain experience. In contrast, patients with vascular dementia show, in general, an increase in pain experienced and new studies are needed to examine whether NAs may underestimate that pain. The capacity of NAs to assess pain in other subtypes of dementia, such as frontotemporal dementia and Lewy body disease, has not so far been examined, and we are only at the beginning of a new and intriguing research episode focused on pain management in dementia.
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